13F-HR filed by Rosalind Advisors, Inc.
Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-12, with 42 holding rows worth $284,527,096.
- Accession
- 0001622627-26-000011
- Filer
- CIK 1622627
- Filed
- 2026-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 42 entries on the cover page, a total value of $284,527,096 stated on the cover page (in dollars after the unit check, H1), rows summing to $284,527,096 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 3,300,389 | $33,003,890 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 3,403,721 | $20,524,438 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 2,613,508 | $20,124,012 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 2,111,700 | $16,576,845 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 450,000 | $14,004,000 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 749,054 | $13,827,537 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,788,475 | $13,807,027 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,410,497 | $13,710,031 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,039,080 | $13,601,557 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 1,657,540 | $13,558,677 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 690,000 | $12,606,300 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 300,000 | $12,456,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 195,045 | $12,393,159 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 2,605,920 | $10,423,680 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 750,000 | $10,042,500 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 1,068,955 | $8,412,676 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 3,905,743 | $6,952,222 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 400,000 | $4,856,000 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 215,871 | $4,343,325 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 3,579,273 | $4,080,371 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 3,839,772 | $3,494,193 | dollars as filed | |
| INVESCO QQQ TR | 46090E953 | PUT | 450,000 | $3,028,500 | dollars as filed | put |
| POLYPID LTD | M8001Q126 | COM | 696,556 | $3,023,053 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 730,488 | $2,118,415 | dollars as filed | |
| SPDR S&P 500 ETF TR | 78462F953 | PUT | 510,000 | $1,886,100 | dollars as filed | put |
| ANAVEX LIFE SCIENCES CORP | 032797950 | PUT | 1,168,600 | $1,880,860 | dollars as filed | put |
| REGENTIS BIOMATERIALS LTD | M8211G108 | ORDINARY SHARES | 251,510 | $1,695,177 | dollars as filed | |
| SPDR SERIES TRUST | 78464A950 | PUT | 1,937,600 | $1,347,600 | dollars as filed | put |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 100,000 | $1,252,000 | dollars as filed | |
| ISHARES TR | 464287955 | PUT | 200,000 | $1,112,000 | dollars as filed | put |
| NEURAXIS INC | 64134X201 | COM | 286,138 | $1,039,253 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 100,000 | $1,039,000 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 385,731 | $848,608 | dollars as filed | |
| BIOFRONTERA INC | 09077D209 | COM NEW | 1,140,764 | $650,235 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N902 | COM | 107,900 | $539,500 | dollars as filed | call |
| VERASTEM INC | 92337C903 | COM NEW | 268,600 | $159,810 | dollars as filed | call |
| UNIQURE NV | N90064901 | CALL | 100,000 | $95,000 | dollars as filed | call |
| REPLIMUNE GROUP INC | 76029N906 | CALL | 230,900 | $11,545 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J906 | CALL | 100,000 | $2,000 | dollars as filed | call |
| REZOLUTE INC | 76200L909 | CALL | 263,100 | $0 | dollars as filed | callValue filed as zero, left out of ratios. |
| REPLIMUNE GROUP INC | 76029N956 | COM | 264,700 | $0 | dollars as filed | putValue filed as zero, left out of ratios. |
| VISTAGEN THERAPEUTICS INC | 92840H900 | COM | 493,400 | $0 | dollars as filed | callValue filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001622627-26-000011 | this filing | 2026-02-12 | acceptance time not in the bulk data set |